REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.51
-0.10 (-1.09%)
At close: Jun 9, 2025, 4:00 PM
9.20
-0.31 (-3.21%)
After-hours: Jun 9, 2025, 7:37 PM EDT

REGENXBIO Market Cap

REGENXBIO has a market cap or net worth of $476.77 million as of June 9, 2025. Its market cap has decreased by -36.86% in one year.

Market Cap
476.77M
Enterprise Value
338.83M
1-Year Change
-36.86%
Ranking
Category
Stock Price
$9.51

Market Cap Chart

Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $476.77M, a decrease of -36.37%. That is a compound annual growth rate of -4.54%.

History

DateMarket Cap% Change
Jun 6, 2025482.00M25.85%
Dec 31, 2024383.00M-51.50%
Dec 29, 2023789.70M-19.57%
Dec 30, 2022981.90M-29.79%
Dec 31, 20211.40B-17.57%
Dec 31, 20201.70B12.32%
Dec 31, 20191.51B0.48%
Dec 31, 20181.50B45.18%
Dec 29, 20171.04B110.87%
Dec 30, 2016491.10M12.43%
Dec 31, 2015436.80M-41.71%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 691.15B
Johnson & Johnson 373.01B
AbbVie 335.32B
Novo Nordisk 332.47B
UnitedHealth Group 275.06B
Abbott Laboratories 232.41B
Novartis AG 231.17B
AstraZeneca 226.14B
Market Cap Rankings